We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

3 FTSE 100 shares I’d buy right now in this fallen market

Why these FTSE 100 (INDEXFTSE:UKX) firms sit firmly on my ‘buy’ list.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

They say that stock markets tend to climb a wall of worry. In other words, bull markets rarely get motoring against a backdrop of positive political, economic and general news. The overall outlook is often foggy, unclear or just plain worrying, but still, shares and stock indices can rise.

And we British investors have plenty to fret about right now. News on the Brexit process has boiled the lid off the cooking pan in recent days, and we are all still contemplating whether or not the stock market in the US will crash further, potentially taking London-listed shares along for the plunge. Is a general economic downturn just around the corner? The list of concerns goes on.

XXX

But I’m focusing on the kind of defensive, dividend-paying stocks that I’d be happy to buy and hold for the long term. Here are three of my favourites:

Pharmaceuticals

GlaxoSmithKline (LSE: GSK) is recovering from a period of weaker earnings following the well-reported patent-cliff challenges big pharmaceutical firms faced over the past few years. At the end of October in the third-quarter report, CEO Emma Walmsley said the firm had made “further good progress” with constant currency sales growth in all three of its business divisions, along with improvements in the operating margin. Adjusted earnings per share grew 14% year-on-year.

City analysts following the firm expect earnings to nudge up in low single-digit percentages this year and next, which is a vast improvement on the falls in annual earnings we were seeing three years ago. I reckon the firm’s research and development pipeline will help to keep it growing over the years to come. Meanwhile, as I write, the forward dividend yield is just over 5%, which looks attractive to me.

Premium drinks

The strength of the Diageo (LSE: DGE) business model is found in the firm’s mighty brands such as Johnnie Walker, Crown Royal, JεB, Buchanan’s Windsor, Smirnoff, Cîroc Ketel One, Captain Morgan, Baileys, Don Julio, Tanqueray and Guinness. Investor returns have been impressive over many years and I think the situation looks set to continue.

People rarely forego their favourite tipple and that situation leads to steady cash inflows for the firm. City analysts expect a mid-single-digit advance in earnings during the current trading year and the directors said in September that trading is going well.

The dividend yield is close to 2.5%, which means the shares are not cheap. But they never are, and I think the firm is worth its valuation. I’d buy and hold for the long haul.

Consumer goods

Brand strength also drives fast-moving consumer goods giant Unilever (LSE: ULVR). The company operates in the beauty, personal care, home care, food and refreshments markets and owns brands such as Ponds, Dove, Cif, Surf, Magnum, Brooke Bond and Hellman’s.

In September’s third-quarter trading statement, chief executive Paul Polman said growth “accelerated” in the quarter across all the firm’s divisions. He explained that the company was “able to increase prices whilst still maintaining good volume growth,” which he thinks reflects the strength of the company’s brands.

City analysts expect earnings to increase around 4% this year and 8% next year. Meanwhile, the dividend yield runs close to 3.3%, which I think represents a fair valuation for the quality of the enterprise.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK has recommended Diageo. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »